- Home
- EMD vs ZVRA Comparison
EMD vs ZVRA Comparison
Compare EMD & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- ZVRA
- Stock Information
- Founded
- EMD 2003
- ZVRA 2006
- Country
- EMD United States
- ZVRA United States
- Employees
- EMD N/A
- ZVRA N/A
- Industry
- EMD Finance/Investors Services
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- EMD Finance
- ZVRA Health Care
- Exchange
- EMD Nasdaq
- ZVRA Nasdaq
- Market Cap
- EMD 583.6M
- ZVRA 481.7M
- IPO Year
- EMD N/A
- ZVRA 2015
- Fundamental
- Price
- EMD $10.12
- ZVRA $12.34
- Analyst Decision
- EMD
- ZVRA Strong Buy
- Analyst Count
- EMD 0
- ZVRA 9
- Target Price
- EMD N/A
- ZVRA $23.25
- AVG Volume (30 Days)
- EMD 248.5K
- ZVRA 1.0M
- Earning Date
- EMD 01-01-0001
- ZVRA 08-12-2025
- Dividend Yield
- EMD 10.25%
- ZVRA N/A
- EPS Growth
- EMD N/A
- ZVRA N/A
- EPS
- EMD N/A
- ZVRA N/A
- Revenue
- EMD N/A
- ZVRA $40,588,000.00
- Revenue This Year
- EMD N/A
- ZVRA $292.31
- Revenue Next Year
- EMD N/A
- ZVRA $78.65
- P/E Ratio
- EMD N/A
- ZVRA N/A
- Revenue Growth
- EMD N/A
- ZVRA 46.47
- 52 Week Low
- EMD $7.85
- ZVRA $5.45
- 52 Week High
- EMD $9.55
- ZVRA $12.55
- Technical
- Relative Strength Index (RSI)
- EMD 62.19
- ZVRA 84.06
- Support Level
- EMD $10.06
- ZVRA $8.58
- Resistance Level
- EMD $10.30
- ZVRA $12.37
- Average True Range (ATR)
- EMD 0.10
- ZVRA 0.51
- MACD
- EMD -0.00
- ZVRA 0.31
- Stochastic Oscillator
- EMD 65.25
- ZVRA 98.47
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.